Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for CMV Infection

Trial Profile

Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for CMV Infection

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Feb 2016

At a glance

  • Drugs Cytomegalovirus immune globulin (Primary) ; Valganciclovir
  • Indications Cytomegalic inclusion disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Feb 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 14 May 2015 Planned End Date changed from 1 Mar 2015 to 1 Dec 2015 as per ClinicalTrials.gov record.
    • 28 Feb 2014 Status changed from recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top